Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them

K. M. ROY; S. J. HUTCHINSON; S. WADD; A. TAYLOR; S. O. CAMERON; S. BURNS; P. MOLYNEAUX; P. G. MCINTYRE; D. J. GOLDBERG

doi:10.1017/S0950268806007035

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

It is estimated that of 50000 persons in Scotland (1% of the county's population), infected with the hepatitis C virus (HCV), around 90% injected drugs. This paper reviews data on the prevalence and incidence of HCV, and the methods used to generate such information, among injecting drug users (IDUs), in Scotland. The prevalence estimate for HCV among IDUs in Scotland as a whole (44% in 2000), is comparable with those observed in many European countries. Incidence rates ranged from 11·9 to 28·4/100 person-years. The data have shaped policy to prevent infection among IDUs and have informed predictions of the number of HCV-infected IDUs who will likely progress to, and require treatment and care for, severe HCV-related liver disease. Although harm reduction interventions, in particular needle and syringe exchanges and methadone maintenance therapy, reduced the transmission of HCV among IDUs during the early to mid-1990s, incidence in many parts of the country remains high. The prevention of HCV among IDUs continues to be one of Scotland's major public health challenges.

Crossref Citations

This article has been cited by the following publications. This list is generated based on data provided by Crossref.

Murray, E and Jones, D 2008. Audit into Blood-Borne Virus Services in Her Majesty's Prison Service. International Journal of STD & AIDS, Vol. 19, Issue. 5, p. 347.

Page-Shafer, Kimberly Pappalardo, Brandee L. Tobler, Leslie H. Phelps, Bruce H. Edlin, Brian R. Moss, Andrew R. Wright, Teresa L. Wright, David J. O'Brien, Thomas R. Caglioti, Sally and Busch, Michael P. 2008. Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates. Journal of Clinical Microbiology, Vol. 46, Issue. 2, p. 499.

Hegazy, D Thurairajah, P Metzner, M Houldsworth, A Shaw, S Kaminski, E Demaine, A G and Cramp, M E 2008. Interleukin 12B gene polymorphism and apparent resistance to hepatitis C virus infection. Clinical and Experimental Immunology, Vol. 152, Issue. 3, p. 538.

Brant, L. J. Ramsay, M. E. Balogun, M. A. Boxall, E. Hale, A. Hurrelle, M. Kaluba, L. Klapper, P. Lewis, D. Patel, B. C. Parry, J. and Irving, W. L. 2008. Diagnosis of acute hepatitis C virus infection and estimated incidence in low‐ and high‐risk English populations. Journal of Viral Hepatitis, Vol. 15, Issue. 12, p. 871.

Martínez-Bauer, Eva Forns, Xavier Armelles, Mercé Planas, Ramon Solà, Ricard Vergara, Mercé Fàbregas, Silvia Vega, Roser Salmerón, Javier Diago, Moisés Sánchez-Tapias, Jose María and Bruguera, Miquel 2008. Hospital admission is a relevant source of hepatitis C virus acquisition in Spain. Journal of Hepatology, Vol. 48, Issue. 1, p. 20.

OLIVEIRA, M. L. A. YOSHIDA, C. F. T. TELLES, P. R. HACKER, M. A. OLIVEIRA, S. A. N. MIGUEL, J. C. do Ó, K. M. R. and BASTOS, F. I. 2009. Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies. Epidemiology and Infection, Vol. 137, Issue. 7, p. 970.

Busch, M. P. and Kleinman, S. H. 2009. Hepatitis C infection: recent insights relevant to transfusion safety. ISBT Science Series, Vol. 4, Issue. 1, p. 72.

ROBERTSON, J. ROY 2009. Commentary on Senn et al. (2009): Primary care is the place to manage hepatitis C in opiate‐dependent patients. Addiction, Vol. 104, Issue. 12, p. 2039.

Jauffret-Roustide, Marie Le Strat, Yann Couturier, Elisabeth Thierry, Damien Rondy, Marc Quaglia, Martine Razafandratsima, Nicolas Emmanuelli, Julien Guibert, Gaelle Barin, Francis and Desenclos, Jean-Claude 2009. A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design. BMC Infectious Diseases, Vol. 9, Issue. 1,

BALOGUN, M. A. MURPHY, N. NUNN, S. GRANT, A. ANDREWS, N. J. TEO, C. G. RAMSAY, M. E. and PARRY, J. V. 2009. Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics. Epidemiology and Infection, Vol. 137, Issue. 7, p. 980.

Etcheverry, María Florencia de Lazzari, Elisa Fuchs, Jonathan D. Meroño, Mercé Sierra, Ernesto Romero, Jorge Del Evans, Jennifer L. Mendez-Arancibia, Eva Jacques, Constanza Rojas, Daniela Segú, Marta Gatell, José María and Joseph, Joan 2010. Pilot Study Assessing HIV Vaccine Trial Readiness Among Female Sex Workers, Injection and Non-injection Drug Users, and Men Who Have Sex with Men in Spain. AIDS and Behavior, Vol. 14, Issue. 3, p. 607.

McDONALD, S. A. HUTCHINSON, S. J. MILLS, P. R. BIRD, S. M. ROBERTSON, C. DILLON, J. F. SPRINGBETT, A. and GOLDBERG, D. J. 2010. Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population. Epidemiology and Infection, Vol. 138, Issue. 3, p. 393.

McDonald, Scott A. Hutchinson, Sharon J. Bird, Sheila M. Robertson, Chris Mills, Peter R. Dillon, John F. and Goldberg, David J. 2011. Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: Increased risk following diagnosis with hepatitis C infection. International Journal of Drug Policy, Vol. 22, Issue. 1, p. 63.

Thurairajah, Prem H. Hegazy, Doha Demaine, Andrew Kaminski, Edward R. and Cramp, Matthew E. 2011. Loss of Virus-specific T-Cell Responses in HCV Exposed Uninfected Injection Drug Users With Drug Rehabilitation. The Journal of Infectious Diseases, Vol. 203, Issue. 6, p. 847.

McDonald, S. A. Hutchinson, S. J. Cameron, S. Bird, S. M. Mills, P. R. McLeod, A. and Goldberg, D. J. 2011. Uptake of hepatitis C antibody testing in patients with end‐stage liver disease in Glasgow, 1993–2007. Journal of Viral Hepatitis, Vol. 18, Issue. 4,

SUTTON, A. J. McDONALD, S. A. PALMATEER, N. TAYLOR, A. and HUTCHINSON, S. J. 2012. Estimating the variability in the risk of infection for hepatitis C in the Glasgow injecting drug user population. Epidemiology and Infection, Vol. 140, Issue. 12, p. 2190.

Allen, Elizabeth J. Palmateer, Norah E. Hutchinson, Sharon J. Cameron, Sheila Goldberg, David J. and Taylor, Avril 2012. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland. International Journal of Drug Policy, Vol. 23, Issue. 5, p. 346.

Vickerman, Peter Martin, Natasha Turner, Katy and Hickman, Matthew 2012. Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings. Addiction, Vol. 107, Issue. 11, p. 1984.

Stallwitz, Anke 2012. The Role of Community-Mindedness in the Self-Regulation of Drug Cultures. p. 325.

Klug, Genevieve M J A Wand, Handan Simpson, Marion Boyd, Alison Law, Matthew Masters, Colin L Matěj, Radoslav Howley, Rachel Farrell, Michael Breithaupt, Maren Zerr, Inga van Duijn, Cornelia Ibrahim-Verbaas, Carla Mackenzie, Jan Will, Robert G Brandel, Jean-Philippe Alperovitch, Annick Budka, Herbert Kovacs, Gabor G Jansen, Gerard H Coulthard, Michael and Collins, Steven J 2013. Intensity of human prion disease surveillance predicts observed disease incidence. Journal of Neurology, Neurosurgery & Psychiatry, Vol. 84, Issue. 12, p. 1372.

Download full list

Article contents

Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them

Abstract

Save article to Kindle

Save article to Dropbox

Save article to Google Drive

Reply to: Submit a response

Your details

You have entered the maximum number of contributors

Conflicting interests